X4 Pharmaceuticals: Q3 Earnings Snapshot
By AP News
Published - Nov 13, 2024, 06:14 AM ET
Last Updated - Dec 16, 2024, 05:27 PM EST
BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Wednesday reported a loss of $36.7 million in its third quarter.
On a per-share basis, the Boston-based company said it had a loss of 18 cents.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The company posted revenue of $560,000 in the period, which also fell short of Street forecasts. Six analysts surveyed by Zacks expected $1.8 million.
